INCYTE CORP 4

Richard A. Hoffman, EVP & General Counsel of Incyte Corp, was awarded RSUs, performance shares, and stock options for Incyte common stock as part of an equity compensation grant on July 16, 2026.

On July 16, 2026, Richard A. Hoffman, EVP & General Counsel of Incyte Corp, received a package of equity-based compensation awards, including 7,395 shares of common stock underlying newly granted restricted stock units (RSUs), 18,487 performance share awards, and employee stock options for 31,923 shares of common stock at an exercise price of $116.65 per share. The RSUs vest 25% annually over four years and are settled in common stock on a one-for-one basis, contributing to a total of 16,861 unvested RSU-linked shares reported as beneficially owned after this grant. The performance shares entitle him to receive up to 200% of one share of common stock per unit based on Incyte’s relative total shareholder return over a three‑year period starting January 1, 2026, with any earned shares vesting on the third anniversary of the grant date, July 16, 2029. The stock options become exercisable in 37 installments, with 25% vesting after one year and the remainder vesting monthly over the following three years, and reflect additional derivative beneficial ownership of common stock. There were no open-market purchases or sales; all transactions were classified as acquisitions under the issuer’s equity compensation plans and are routine incentive and retention awards rather than discretionary trading by the insider.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0002098091-26-000005

Alert Tier

5